Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling ...
Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in ...
France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...
Private equity firm Clayton Dubilier & Rice (CD&R) is nearing a deal to acquire Sanofi's consumer health unit for about 15 ...
Operating independently within Sanofi, Opella has resources allocated for research and development, production, and digital ...
The French government is looking at options including state-owned investment bank BPIfrance taking a stake in the consumer ...
Banks including Goldman Sachs Group Inc and Citigroup Inc. are among 22 banks set to provide Clayton Dubilier & Rice with ...
In September, Bloomberg reported that Sanofi had received two separate bids from CD&R and rival PAI Partners for the Opella unit. CD&R has kept away interest from rival PAI Partners for the unit ...
An offer from US private equity firm Clayton, Dubilier & Rice has beaten rivals, pursuing French pharmaceutical company Sanofi’s consumer healthcare division, in what is set to be the largest European ...
Sanofi has chosen US private equity firm Clayton, Dubilier & Rice to advance acquisition talks for its consumer health unit, ...
Sanofi to sell consumer health unit for $16.4 billion to private equity firm Clayton Dubilier & Rice in upcoming deal ...
Clayton Dubilier & Rice (CD&R) has entered negotiations to acquire a 50 percent controlling stake in Sanofi’s consumer healthcare business Opella.